Loading...
ROCO
4198
Market cap31mUSD
Jul 09, Last price  
45.40TWD
1D
8.74%
1Q
11.00%
Jan 2017
-90.31%
IPO
-95.37%
Name

S&S Healthcare Holding Ltd

Chart & Performance

D1W1MN
ROCO:4198 chart
P/E
P/S
4.92
EPS
Div Yield, %
Shrs. gr., 5y
14.40%
Rev. gr., 5y
15.04%
Revenues
204m
-15.00%
181,729,000101,361,000122,354,000254,437,000275,113,000240,248,000204,212,000
Net income
-47m
L+14.57%
-152,383,000-114,865,000-95,394,000-66,885,000103,609,000-41,279,000-47,295,000
CFO
-27m
L-48.77%
0-58,624,000-70,524,000-72,905,000-68,098,000-52,036,000-26,657,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

S&S Healthcare Holding Ltd. is dedicated to the research, manufacturing, and global commercialization of medical imaging equipment. The company's operations extend across international markets, including significant presences in Taiwan, the United States, and Switzerland. Its product portfolio encompasses advanced digital diagnostic X-ray systems, alongside the engineering and production of devices for bone densitometry and body composition assessment. Established in 1988, S&S Healthcare maintains its headquarters in Taipei, Taiwan. The firm adopted its current name in August 2020, having previously operated as Swissray Global Healthcare Holding Ltd.
IPO date
Nov 08, 2013
Employees
Domiciled in
TW
Incorporated in
TW

Valuation

Title
TWD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT